A detailed history of Clayton Financial Group LLC transactions in Viatris Inc stock. As of the latest transaction made, Clayton Financial Group LLC holds 210 shares of VTRS stock, worth $2,251. This represents 0.0% of its overall portfolio holdings.

Number of Shares
210
Holding current value
$2,251
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 21, 2026

BUY
$9.74 - $11.2 $2,045 - $2,352
210 New
210 $2.62 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Clayton Financial Group LLC Portfolio

Follow Clayton Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clayton Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clayton Financial Group LLC with notifications on news.